Skip Navigation
National Institutes of Health: National Cancer Institute: Division of Cancer Control and Population Sciences
Grant Details

Grant Number: 5P50DA019706-10 Interpret this number
Primary Investigator: Baker, Timothy
Organization: University Of Wisconsin-Madison
Project Title: Tobacco Dependence: Treatment and Outcomes
Fiscal Year: 2008
Back to top


Crucial knowledge gaps hinder our ability to treat nicotine dependence optimally. We know too little about the relative efficacies of pharmacotherapies in both clinical trials and real-world contexts. We know too little about how to deliver treatment: e.g., how to match patients with pharmacotherapies, how to incorporate treatment seamlessly into health care delivery systems and how to combine pharmacotherapies. In addition, we know too little about the global, long-term consequences of quit attempts: e.g., the downstream physiological, psychosocial, and health care utilization effects of continuing to smoke versus successfully quitting. Finally, we lack understanding of the mechanisms by which treatments work. These gaps will be addressed via four research projects and supportive cores. The first project (N=1520) will contrast efficacies of five different pharmacotherapies and a placebo, explore their mechanisms of action and yield algorithms for their optimal use. The second project will follow from the first project participants for at least 3 years and capture the diverse physical and psychosocial health outcomes of a quit attempt. The third project (N=1320) will study the active pharmacotherapies used in the first project, but in an effectiveness, primary care context. Data will address treatment utilization, success, and validate treatment algorithms. The fourth project will track from the third project subjects along with anonymous controls and reveal the impact of cessation on health care utilization and costs within a large network of primary care clinics. In addition, the UW-TTURC proposal includes an Administrative Core providing shared resources and infrastructure, a Career Development Core to increase the number of clinician-scientists entering the field of tobacco control research, and a Developmental Research Core to support innovative tobacco control research. The proposed work will advance the understanding and effectiveness of tobacco dependence treatment through integrated transdisciplinary research and result in more smokers quitting successfully.

Back to top


Assessing Tobacco Dependence: A Guide To Measure Evaluation And Selection
Authors: Piper M.E. , McCarthy D.E. , Baker T.B. .
Source: Nicotine & Tobacco Research : Official Journal Of The Society For Research On Nicotine And Tobacco, 2006 Jun; 8(3), p. 339-51.
PMID: 16801292
Related Citations

A Candidate Gene Approach Identifies The Chrna5-a3-b4 Region As A Risk Factor For Age-dependent Nicotine Addiction
Authors: Weiss R.B. , Baker T.B. , Cannon D.S. , von Niederhausern A. , Dunn D.M. , Matsunami N. , Singh N.A. , Baird L. , Coon H. , McMahon W.M. , et al. .
Source: Plos Genetics, 2008 Jul; 4(7), p. e1000125.
PMID: 18618000
Related Citations

Transdisciplinary Tobacco Use Research Centers: Research Achievements And Future Implications
Authors: Baker T.B. , Cummings K.M. , Hatsukami D.K. , Johnson C.A. , Lerman C. , Niaura R. , O'Malley S.S. .
Source: Nicotine & Tobacco Research : Official Journal Of The Society For Research On Nicotine And Tobacco, 2009 Oct; 11(10), p. 1231-44.
PMID: 19633277
Related Citations

Pharmacotherapy Effects On Smoking Cessation Vary With Nicotine Metabolism Gene (cyp2a6)
Authors: Chen L.S. , Bloom A.J. , Baker T.B. , Smith S.S. , Piper M.E. , Martinez M. , Saccone N. , Hatsukami D. , Goate A. , Bierut L. .
Source: Addiction (abingdon, England), 2014 Jan; 109(1), p. 128-37.
PMID: 24033696
Related Citations

Interplay Of Genetic Risk (chrna5) And Environmental Risk (partner Smoking) On Cigarette Smoking Reduction
Authors: Chen L.S. , Baker T.B. , Piper M.E. , Smith S.S. , Gu C. , Grucza R.A. , Smith G.D. , Munafo M. , Bierut L.J. .
Source: Drug And Alcohol Dependence, 2014-10-01 00:00:00.0; 143, p. 36-43.
PMID: 25073833
Related Citations

Organic Cation Transporter Variation And Response To Smoking Cessation Therapies
Authors: Bergen A.W. , Javitz H.S. , Krasnow R. , Michel M. , Nishita D. , Conti D.V. , Edlund C.K. , Kwok P.Y. , McClure J.B. , Kim R.B. , et al. .
Source: Nicotine & Tobacco Research : Official Journal Of The Society For Research On Nicotine And Tobacco, 2014 Dec; 16(12), p. 1638-46.
PMID: 25143296
Related Citations

Drug Metabolizing Enzyme And Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, And Cigarette Consumption
Authors: Bergen A.W. , Michel M. , Nishita D. , Krasnow R. , Javitz H.S. , Conneely K.N. , Lessov-Schlaggar C.N. , Hops H. , Zhu A.Z. , Baurley J.W. , et al. .
Source: Plos One, 2015; 10(7), p. e0126113.
PMID: 26132489
Related Citations

Genetic Variation (chrna5), Medication (combination Nicotine Replacement Therapy Vs. Varenicline), And Smoking Cessation
Authors: Chen L.S. , Baker T.B. , Jorenby D. , Piper M. , Saccone N. , Johnson E. , Breslau N. , Hatsukami D. , Carney R.M. , Bierut L.J. .
Source: Drug And Alcohol Dependence, 2015-09-01 00:00:00.0; 154, p. 278-82.
PMID: 26142345
Related Citations

The Value Of Control Conditions For Evaluating Pharmacogenetic Effects
Authors: Chen L.S. , Baker T.B. , Bierut L.J. .
Source: Pharmacogenomics, 2015 Dec; 16(18), p. 2005-6.
PMID: 26607722
Related Citations